Kolexia
Cacheux Victoria Oncologie hémato.
Cacheux Victoria
Oncologie hémato.
Hôpital Estaing
Clermont-Ferrand, France
98 Activités
5 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie-lymphome lymphoblastique à précurseurs B et T Lymphomes Lymphome à cellules du manteau Lymphome T Maladie résiduelle Leucémie-lymphome lymphoblastique à précurseurs T Chromosome Philadelphie Leucémie aigüe myéloïde

Collaborateurs

Voir plus
Blin Nicolas
Blin Nicolas
Hôpital Hôtel-Dieu Nantes, Nantes, France
Tavernier-Tardy Emmanuelle
Tavernier-Tardy Emmanuelle
Institut de Cancérologie de la Loire Lucien Neuwirth, Saint-Priest-en-Jarez, France
Casasnovas Rene-Olivier
Casasnovas Rene-Olivier
Hôpital François Mitterrand, Dijon, France
Balsat Mizzon Marie
Balsat Mizzon Marie
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
A+A
228 collaboration(s)
Dernière en 2023
B3TSI
208 collaboration(s)
Dernière en 2023
IQVIA
128 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
119 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LyMa101: Phase II Study to Evaluate the Efficacy of Upfront Obinutuzumab in Mantle Cell Lymphoma Patients Treated by DHAP Followed by Autologous Transplantation Plus Obinutuzumab Maintenance Then MRD Driven Maintenance
Essai Clinique (The Lymphoma Academic Research Organisation)   13 mars 2024
Faster clinical decisions in B-cell acute lymphoblastic leukaemia: A single flow cytometric 12-colour tube improves diagnosis and minimal residual disease follow-up.
British journal of haematology   03 mars 2024
PHILEOS: Haemophilia and Bone Loss PHILEOS Study
Essai Clinique (CHU Saint-Étienne)   29 décembre 2023
Obinutuzumab Versus Rituximab in Transplant Eligible Untreated MCL Patients, a Matching Comparison between the Lyma and Lyma-101 Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
Oncogenetic-Driven Targeted Therapy for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia : A French ALL-Target Observatory Report
65th ASH Annual Meeting Abstracts   02 novembre 2023
Exploring the Heterogeneity of Response to Blinatumomab in High-Risk Philadelphia-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: An Analysis from the QUEST Sub-Study of the Graall-2014/B Trial
65th ASH Annual Meeting Abstracts   02 novembre 2023
MTSA: A Phase II, Multicenter, Open Label Study Evaluating the Efficacy and the Tolerance of Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia (MTSA)
Essai Clinique (CHU Saint-Étienne)   04 mai 2023
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma: A Randomized Phase II Trial Evaluating Ibrutinib Plus CD20 Ab and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   16 mars 2023
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma.
Haematologica   01 septembre 2022
Hemophagocytosis by acute myeloid leukemia blasts associated to poor clinical outcomes.
EJHaem   05 février 2022